Nancy Chang, Ph.D.
Board Member
Galera Therapeutics, Inc. (GRTXD)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Nancy Chang, Ph.D.
Nancy Chang, Ph.D. is recorded as Board Member at Galera Therapeutics, Inc. (GRTXD). Galera Therapeutics, Inc. reported in an 8-K filed December 31, 2024 that Nancy Chang, Ph.D. was appointed Class I director, effective December 30, 2024.
“On December 30, 2024, effective immediately after the First Effective Time, Nancy Chang, Ph.D. and Michael Friedman were appointed as members of the Board as Class I directors (such appointees, collectively the "Director Appointees").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-12-30–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Galera Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Joel Sussman Chief Accounting Officer
- Michael Friedman Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.